Most commonly, in lung carcinomas carrying STK11 alterations, the AMPKα1 gene (PRKAA1) is often amplified, while mutations in the PRKAA2 gene occur less frequently (Monteverde et al., 2015). Here, PRKAA1 is linked to lung carcinoma.